HIV-1 protease-IN-12

Modify Date: 2024-01-11 09:06:35

HIV-1 protease-IN-12 structure	Common Name	HIV-1 protease-IN-12
	CAS Number	2925287-59-6	Molecular Weight	489.63
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₅H₃₅N₃O₅S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HIV-1 protease-IN-12

HIV-1 protease-IN-12 (compound 35b) is a HIV-1 protease inhibitor with an IC50 of 0.51 nM. HIV-1 protease-IN-12 also inhibits drug-resistant variant[1].

Name	HIV-1 protease-IN-12

Description	HIV-1 protease-IN-12 (compound 35b) is a HIV-1 protease inhibitor with an IC50 of 0.51 nM. HIV-1 protease-IN-12 also inhibits drug-resistant variant[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Metabolic Enzyme/Protease >> HIV Protease
References	[1]. Huiyu Zhou, et al. Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant. Eur J Med Chem. 2023 Jul 5;255:115389.

Molecular Formula	C₂₅H₃₅N₃O₅S
Molecular Weight	489.63

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

HIV-1 protease-IN-12

Use of HIV-1 protease-IN-12

Names

HIV-1 protease-IN-12 Biological Activity

Chemical & Physical Properties